Tenaya Therapeutics, Inc.
- TNYA
- NASDAQ
- Biotechnology
- Gene Therapy (Cardiovascular)
- Heart Disease Treatments
$0.38
Today −0.81%Quote Oct 19, 2026, 08:00 PM UTC
−43.37%over the last month
Max drawdown −44.2%From 1-month high −44.2%3 months −53.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Tenaya Therapeutics
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
70
Founded
2016
Market value
$84.7M
Quote Oct 19
Floor
$0.36
4.6% below price
Resistance
$0.47
24.1% above price
Price vs analyst targets
6 analysts
Lowest target
$2.00Highest target
$3.00
$2.00Highest target
$3.00
- Price $0.38
- Average target $2.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 517% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TNYAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free